Abstract:Infections that result in natural or manmade spread of lethal biological agents are a concern and require national and focused preparedness. In this manuscript, as part of an early diagnostics and pathogen treatment strategy, we have focused on extracellular vesicles (EVs) that arise following infections. Although the field of biodefense does not currently have a rich resource in EVs literature, none the less, similar pathogens belonging to the more classical emerging and non-emerging diseases have been studied in their EV/exosomal contents and function. These exosomes are formed in late endosomes and released from the cell membrane in almost every cell type in vivo. These vesicles contain proteins, RNA, and lipids from the cells they originate from and function in development, signal transduction, cell survival, and transfer of infectious material. The current review focuses on how different forms of infection exploit the exosomal pathway and how exosomes can be exploited artificially to treat infection and disease and potentially also be used as a source of vaccine. Virally-infected cells can secrete viral as well as cellular proteins and RNA in exosomes, allowing viruses to cause latent infection and spread of miRNA to nearby cells prior to a subsequent infection. In addition to virally-infected host cells, bacteria, protozoa, and fungi can all release small vesicles that contain pathogen-associated molecular patterns, regulating the neighboring uninfected cells. Examples of exosomes from both virally and bacterially infected cells point toward a re-programming network of pathways in the recipient cells. Finally, many of these exosomes contain cytokines and miRNAs that in turn can effect gene expression in the recipient cells through the classical toll-like receptor and NFκB pathway. Therefore, although exosomes do not replicate as an independent entity, they however facilitate movement of infectious material through tissues and may be the cause of many pathologies seen in infected hosts.

Dual Role of Extracellular Vesicles as Orchestrators of Emerging and Reemerging Virus Infections

Emerging roles of extracellular vesicles in mediating RNA virus infection

Emerging Roles of Extracellular Vesicles in COVID‐19, a Double‐edged Sword?

The Role of Extracellular Vesicles in Pandemic Viral Infections

Extracellular Vesicles: A Novel Mode of Viral Propagation Exploited by Enveloped and Non-Enveloped Viruses

Role of Extracellular Vesicles in Viral and Bacterial Infections: Pathogenesis, Diagnostics, and Therapeutics

Extracellular vesicles in virus infection and pathogenesis

Extracellular Vesicles: Roles in Human Viral Infections, Immune-Diagnostic, and Therapeutic Applications

The Ambiguous Roles of Extracellular Vesicles in HIV Replication and Pathogenesis

A Comprehensive Insight into the Role of Exosomes in Viral Infection: Dual Faces Bearing Different Functions

Extracellular Vesicles in Pathogenic Infection, Transmission, and Immunity

Emerging roles of cytoskeletal transport and scaffold systems in human viral propagation

Extracellular vesicles in the pathogenesis of neurotropic viruses

Their Roles in Viral Transmission, Immune Evasion, and Inflammation

Extracellular vesicles from infected cells: potential for direct pathogenesis

Extracellular Vesicles Regulated by Viruses and Antiviral Strategies.

The Role of the Host Ubiquitin System in Promoting Replication of Emergent Viruses

Extracellular Vesicle‐Inspired Therapeutic Strategies for the COVID‐19

Exosomal transmission of viruses, a two-edged biological sword

Extracellular vesicles and infectious diseases: new complexity to an old story

A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention